These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38870752)

  • 1. Comparative immunogenic and immunoprotective activities of PCV2d Cap and Rep antigens delivered by an efficient eukaryotic expression system engineered into a Salmonella vaccine vector.
    Lloren KKS; Sivasankar C; Lee JH
    Vet Microbiol; 2024 Aug; 295():110151. PubMed ID: 38870752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral vaccination with attenuated Salmonella enterica serovar Typhimurium expressing Cap protein of PCV2 and its immunogenicity in mouse and swine models.
    Xu XG; Zhao HN; Zhang Q; Ding L; Li ZC; Li W; Wu HY; Chuang KP; Tong DW; Liu HJ
    Vet Microbiol; 2012 Jun; 157(3-4):294-303. PubMed ID: 22326539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
    Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
    Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A candidate DNA vaccine encoding a fusion protein of porcine complement C3d-P28 and ORF2 of porcine circovirus type 2 induces cross-protective immunity against PCV2b and PCV2d in pigs.
    Hou Z; Wang H; Feng Y; Li Q; Li J
    Virol J; 2019 May; 16(1):57. PubMed ID: 31046793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
    Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
    Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
    Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
    Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
    Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
    Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
    Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
    Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
    Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity Evaluation of Modified Adenovirus Vaccines Expressing Porcine Circovirus Type 2 Capsid Protein in Pigs.
    Li D; Xu D; Wang Z; Du Q; Chang L; Zhao X; Huang Y; Tong D
    Viral Immunol; 2017 Mar; 30(2):111-119. PubMed ID: 27996636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
    Jung BK; Kim HR; Lee YH; Jang H; Chang KS
    J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsid proteins from PCV2a genotype confer greater protection against a PCV2b strain than those from PCV2b genotype in pigs: evidence for PCV2b strains becoming more predominant than PCV2a strains from 2000 to 2010s.
    Huang L; Wang Y; Wei Y; Chen D; Liu D; Du W; Xia D; Wu H; Feng L; Liu C
    Appl Microbiol Biotechnol; 2016 Jul; 100(13):5933-43. PubMed ID: 27020283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
    J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live-Attenuated
    Lloren KKS; Lee JH
    Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
    Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
    Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
    Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
    Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity and different cross-neutralization capability of porcine circovirus type 2 isolates recently circulating in South Korea.
    Kang SJ; Kang H; You SH; Lee HJ; Lee N; Hyun BH; Cha SH
    BMC Vet Res; 2020 Sep; 16(1):334. PubMed ID: 32928247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
    Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
    Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.